Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathic
disease in Taiwan. The mass neonatal screening of G6PD deficiency by fluorometric spot
test in Taiwan was started with a pilot program in 1984. The nationwide screening was
started on July 1, 1987, and a follow-up system comprising of eighteen referral hospitals,
including outlying islands, was organized for confirmatory test, medical care and genetic
counseling. From July 1987 to December 1997, 2,971,192 heel blood samples collected on …

Objective: This study was carried out to detect the incidence of erythrocytic Glucose-6-
Phosphate dehydrogenase (G-6-PD) deficiency, to compare the incidence of
hyperbilirubinernia in G-6-PD deficient neonates as compared to G-6-PD normal neonates
and to asses the usefulness of neonatal screening for G-6-PD deficiency. Method: In a
retrospective hospital based study 2,479 male and female neonates consecutively born at
Indraprastha Apollo hospital between July 1998 to June 2003 who were screened for G-6 …